| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |